← Back to Clinical Trials
Recruiting NCT06536452
Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
Trial Parameters
Condition Chronic Lymphocytic Leukemia
Sponsor Mayo Clinic
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 40 Years
Max Age N/A
Start Date 2016-11-18
Completion 2028-11-18
All Conditions
Interventions
Non-Interventional Study
Brief Summary
This study evaluates hematopoiesis to determine how MBL/CLL affected bone marrow responds to fight off infections in the body.
Eligibility Criteria
Inclusion Criteria: * Subjects in the CLL cohort who are eligible for these studies will have a clinically established diagnosis of CLL as assessed by flow cytometry and will include subjects who * Remain untreated * Are currently being treated * Who have already been treated * Subjects in the MBL cohort will have a clinically established diagnosis of MBL * Healthy age-matched control subjects * Healthy younger control subjects aged \> 40 years Exclusion Criteria: * Anyone under 40 * Healthy control subjects must not have a diagnosis of CLL or MBL
Related Trials
NCT04505254
Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia
View Trial →
NCT06536452
Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
View Trial →
NCT06812715
Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment
View Trial →